Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

被引：6

作者：

Erdogdu, Batuhan ^{[1
]}

Cinar, Olgu Erkin ^{[1
]}

Malkan, Umit Yavuz ^{[1
]}

Aksu, Salih ^{[1
]}

Demiroglu, Haluk ^{[1
]}

Buyukasik, Yahya ^{[1
]}

Goker, Hakan ^{[1
]}

Sayinalp, Nilgun ^{[1
]}

Haznedaroglu, Ibrahim Celalettin ^{[1
]}

机构：

[1] Hacettepe Univ, Fac Med, Dept Hematol, Ankara, Turkey

来源：

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI | 2022年 / 32卷 / 01期

关键词：

D O I：

10.4999/uhod.226097

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Our second case is a 49-year-old female patient, two days after receiving BNT162b2 mRNA COVID-19 vaccine, petechiae was started in arms and then in lower extremities. The complaints of weakness and fatigue continued to increase within days. The patient, who was admitted to the hospital ten days later with these complaints, was found to have bi-cytopenia. Bone marrow aspiration and biopsy reported that 20-30% stained with cd19 diffuse positive Terminal deoxynucleotidyl transferase (TdT) in blastic cells. HyperCVAD chemotherapy was started with the diagnosis of b-acute lymphoOur third case is a 57-year-old male patient, difficulty in swallowing, and oral ulceration after vaccination of BNT162b2 mRNA COVID-19 vac

引用

页码：65 / 67

页数：3

共 50 条

[41] Haematological changes and adverse events associated with BNT162b2 mRNA COVID-19 vaccine in patients receiving clozapine-Findings from an audit
Lim, Shuli
Liew, Emily
Leo, Amy
Ng, Boon Tat
Lee, Jimmy
ACTA PSYCHIATRICA SCANDINAVICA, 2022, 146 (02) : 179 - 181
[42] Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA COVID-19 vaccine
Flego, Davide
Cesaroni, Simone
Romiti, Giulio F.
Corica, Bernadette
Marrapodi, Ramona
Scafa, Noemi
Maiorca, Francesca
Lombardi, Ludovica
Pallucci, Davide
Pulcinelli, Fabio
Raparelli, Valeria
Visentini, Marcella
Cangemi, Roberto
Piconese, Silvia
Alvaro, Domenico
Polimeni, Antonella
Basili, Stefania
Stefanini, Lucia
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (04) : 961 - 974
[43] Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine
Aoki, Natsuko
Saruta, Yusuke
Tanaka, Sae
Nakajima, Riho
Sano, Hozumi
Sano, Shigetoshi
JOURNAL OF DERMATOLOGY, 2021, 48 (12): : E596 - E597
[44] BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
Vizcarra, Pilar
Haemmerle, Johannes
Velasco, Hector
Velasco, Tamara
Fernandez-Escribano, Marina
Vallejo, Alejandro
Casado, Jose L.
VACCINE, 2021, 39 (51) : 7367 - 7374
[45] Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
Kazuyuki Saito
Taro Shimizu
Katsue Suzuki-Inoue
Tatsuhiro Ishida
Yoshiaki Wada
Neurological Sciences, 2021, 42 : 4433 - 4435
[46] Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Tal Patalon
Yaki Saciuk
Asaf Peretz
Galit Perez
Yoav Lurie
Yasmin Maor
Sivan Gazit
Nature Communications, 13
[47] BNT162b2 Vaccine Booster and Covid-19 Mortality
Pilz, Stefan
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (10): : 1000 - 1000
[48] Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine
del Saz, Borja Somovilla
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (12)
[49] Rhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent male
Sutcu, Murat
Gul, Doruk
Atik, Fatih
Kara, Manolya
MALAWI MEDICAL JOURNAL, 2022, 34 (02) : 154 - 156
[50] Adverse reactions of BNT162b2 vaccine booster against COVID-19 in Japan
Nishizawa, Toshinori
Jinta, Torahiko
Koyamada, Ryosuke
Uehara, Yuki
Taki, Fumika
Arioka, Hiroko
JOURNAL OF GENERAL AND FAMILY MEDICINE, 2022, 23 (05): : 360 - 362

← 1 2 3 4 5 →